CEF Control ImmuneSelect Peptide Pool Premium

CEF Control ImmuneSelect Peptide Pool Premium

Product overview

The CEF Control ImmuneSelect peptide pool contains 32 peptides from human cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and Influenza A virus (IAV), derived from the following proteins:

• Matrix protein (IAV)
• Nucleoprotein (IAV)
• RNA polymerase (IAV)
• Polymerase PA (IAV)
• BZLF1 (EBV)
• EBNA-3A/-3B/-3C (EBV)
• LMP2A (EBV)
• BMLF1 (EBV)
• BRLF1 (EBV)
• IE-1 (CMV)
• Pp65 (CMV)

The peptide sequences cover MHC-I restricted epitopes, and the minimum purity of each peptide is ≥85%, with an average purity of >95% as determined by HPLC-MS.

Key product information

The CEF Control ImmuneSelect Peptide Pool Premium is supplied by Virax Biolabs under catalog number 1401-07. It is categorized as Peptide Pools and is intended for research use according to the applicable product documentation.

Research applications

Suitable for in vitro immune-response studies and T-cell stimulation research workflows. Confirm protocol requirements, sample compatibility, and intended use before ordering.

Technical specifications

Ordering and configuration

Contact Scientific China for availability, pack size or configuration options, minimum order quantity, lead time, and a formal quotation for the CEF Control ImmuneSelect Peptide Pool Premium.